I’ve got a quick break in the schedule. The office is insanely busy, but perhaps the rain is dampening the crowds.
Yesterday I started the day with a run. It wasn’t too hot yet (about 77) and the sun wasn’t up. It. Felt. Great! About a mile into it, I heard some distant thunder. No big deal. Then more. And lightning. I turned around and picked up the pace a bit back toward the trail head. About half a mile from the end, the skies opened up. Within a few steps I was soaked to the bone—but I wasn’t hot. It turned out to be one of my best speed runs.
There’s been a lot of news about the latest diet pill, this one with an unpronounceable name. Qsymia is a combination of two older drugs, phentiramine and topiramate. Phentiramine, a stimulant, is somewhat effective, but in my opinion not safe for long term use. Topiramate is also good at curbing appetite, but the other side effects are often intolerable. But let’s imagine that Qsymia is tolerated by most users. How well will it work? The studies have shown impressive weight loss (if I recall correctly, about 10% body weight).
This optimism should be tempered by more than just the possible side effects of the drug. How long will weight loss be maintained? If past experiences hold, the weight loss will be temporary. And as with most new drugs, we can expect a decline effect where initial positive findings appear to dwindle as more studies are done over time.
So I guess I’ll stick to running for now. There’s no pill to replace exercise for good cardiovascular health.